Abstract:"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To develop and validate a deep learning (DL) method to detect and segment enhancing and nonenhancing cellular tumor on pre- and posttreatment MRI scans of patients with glioblastoma and to predict overall survival (OS) and progression-free survival (PFS). Materials and Methods This retrospective study included 1397 MRIs in 1297 patients with glioblastoma, including an internal cohort of 243 MRIs (January 2010-June 2022) for model training and cross-validation and four external test cohorts. Cellular tumor maps were segmented by two radiologists based on imaging, clinical history, and pathology. Multimodal MRI with perfusion and multishell diffusion imaging were inputted into a nnU-Net DL model to segment cellular tumor. Segmentation performance (Dice score) and performance in detecting recurrent tumor from posttreatment changes (area under the receiver operating characteristic curve [AUC]) were quantified. Model performance in predicting OS and PFS was assessed using Cox multivariable analysis. Results A cohort of 178 patients (mean age, 56 years ± [SD]13; 121 male, 57 female) with 243 MRI timepoints, as well as four external datasets with 55, 70, 610 and 419 MRI timepoints, respectively, were evaluated. The median Dice score was 0.79 (IQR:0.53-0.89) and the AUC for detecting residual/recurrent tumor was 0.84 (95% CI:0.79- 0.89). In the internal test set, estimated cellular tumor volume was significantly associated with OS (hazard ratio [HR] = 1.04/mL, P < .001) and PFS (HR = 1.04/mL, P < .001) when adjusting for age, sex and gross total resection status. In the external test sets, estimated cellular tumor volume was significantly associated with OS (HR = 1.01/mL, P < .001) when adjusting for age, sex and gross total resection status. Conclusion A DL model incorporating advanced imaging could accurately segment enhancing and nonenhancing cellular tumor, classify recurrent/residual tumor from posttreatment changes, and predict OS and PFS in patients with glioblastoma. ©RSNA, 2024.

WHO 2016 subtyping and automated segmentation of glioma using multi-task deep learning

Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks

Comprehensive Genomic Subtyping of Glioma Using Semi-Supervised Multi-Task Deep Learning on Multimodal MRI

Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified Training

Automated MRI based pipeline for glioma segmentation and prediction of grade, IDH mutation and 1p19q co-deletion

Glioma Segmentation Using a Novel Unified Algorithm in Multimodal MRI Images

U-Net Based Segmentation and Characterization of Gliomas

Non-invasive classification of IDH mutation status of gliomas from multi-modal MRI using a 3D convolutional neural network

MRI-based classification of IDH mutation and 1p/19q codeletion status of gliomas using a 2.5D hybrid multi-task convolutional neural network

Automatic Semantic Segmentation of Brain Gliomas from MRI Images Using a Deep Cascaded Neural Network

SGPNet: A Three-Dimensional Multitask Residual Framework for Segmentation and IDH Genotype Prediction of Gliomas

A deep convolutional neural network for the automatic segmentation of glioblastoma brain tumor: Joint spatial pyramid module and attention mechanism network

Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor on Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma

Multi-modal Brain Tumor Segmentation Using Stacked Denoising Autoencoders

A Fully Automated Multimodal MRI-Based Multi-Task Learning for Glioma Segmentation and IDH Genotyping.

Deep Learning-Based Automated Post-Operative Gross Tumor Volume Segmentation in Glioblastoma Patients

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study

A transformer-based multi-task deep learning model for simultaneous infiltrated brain area identification and segmentation of gliomas

Auto-segmentation of Adult-Type Diffuse Gliomas: Comparison of Transfer Learning-Based Convolutional Neural Network Model Vs. Radiologists

A multicenter study on deep learning for glioblastoma auto-segmentation with prior knowledge in multimodal imaging